Personal information

United States

Activities

Employment (3)

Novartis Institutes for BioMedical Research Inc: Cambridge, MA, US

2022-03-14 to present | Senior Expert I Data Science (Discovery Sciences)
Employment
Source: Self-asserted source
Kumar Veerapen

Massachusetts General Hospital: Boston, MA, US

2016-07-11 to 2022-02-28 | Postdoctoral Research Fellow (Analytic and Translational Genetics Unit)
Employment
Source: Self-asserted source
Kumar Veerapen

UCSI University: Kuala Lumpur, Kuala Lumpur, MY

2009-01-03 to 2011-07-20 | Tutor (Faculty of Applied Sciences)
Employment
Source: Self-asserted source
Kumar Veerapen

Education and qualifications (2)

University of Miami: Miami, Florida, US

2011-08-16 to 2016-04-29 | PhD (Biochemistry and Molecular Biology)
Education
Source: Self-asserted source
Kumar Veerapen

UCSI University: Kuala Lumpur, Kuala Lumpur, MY

2005-08-25 to 2008-12-15 | B Sc (First Class Honors) (Faculty of Applied Sciences)
Education
Source: Self-asserted source
Kumar Veerapen

Works (8)

Identification of 64 new risk loci for major depression, refinement of the genetic architecture and risk prediction of recurrence and comorbidities

2022-08-25 | Preprint
Contributors: Thomas D. Als; Mitja Kurki; Jakob Grove; Georgios Voloudakis; Karen Therrien; Elisa Tasanko; Trine Tollerup Nielsen; Joonas Naamanka; Kumar Veerapen; Daniel Levey et al.
Source: check_circle
Crossref

The Genetics of Preterm Birth

2016 | Dissertation or Thesis
Source: Self-asserted source
Kumar Veerapen

Association of leptin/receptor and TNF-$α$ gene variants with adolescent obesity in Malaysia

Pediatrics International
2014 | Journal article
Source: Self-asserted source
Kumar Veerapen

Bridging the Gaps Between the Histopathological and Demographic Risk Factors of Preterm Birth in a Unique Miami Inner-City Population

Fetal and pediatric pathology
2014 | Journal article
Source: Self-asserted source
Kumar Veerapen

Differential expression of SDF-1 isoforms in bladder cancer

The Journal of urology
2014 | Journal article
Source: Self-asserted source
Kumar Veerapen

Preterm Deliveries in a Unique Miami Inner-city Population: Connecting Histopathological and Demographic Risk Factors.

Pediatric & Developmental Pathology
2013 | Journal article
Source: Self-asserted source
Kumar Veerapen

4-methylumbeliferone, an HA synthesis inhibitor, inhibits EMT determinants in bladder cancer cell lines

2012 | Other
Source: Self-asserted source
Kumar Veerapen

ASSOCIATION OF FTO 17817449 VARIANT WITH OBESITY AND THE ENERGY INTAKE AND PHYSICAL ACTIVITY PARAMETERS IN MALAYSIAN ADOLESCENTS

Journal article
Source: Self-asserted source
Kumar Veerapen

Peer review (7 reviews for 5 publications/grants)

Review activity for BMC genomic data. (2)
Review activity for BMC medical genetics (2)
Review activity for BMC medical genomics. (1)
Review activity for Molecular genetics and genomics. (1)
Review activity for PloS one. (1)